KALMPEN Trademark

Trademark Overview

On Friday, November 15, 2019, a trademark application was filed for KALMPEN with the United States Patent and Trademark Office. The USPTO has given the KALMPEN trademark a serial number of 88694201. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Bioxcel Therapeutics, Inc.. The KALMPEN trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceuticals for the treatment of agitation; injectable pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal and other related central nervous system disorders

General Information

Serial Number88694201
Word MarkKALMPEN
Filing DateFriday, November 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 13, 2020

Trademark Statements

Goods and ServicesInjectable pharmaceuticals for the treatment of agitation; injectable pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal and other related central nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioxcel Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06516
Party NameBioxcel Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06516

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2023SOU EXTENSION 5 GRANTED
Tuesday, June 6, 2023SOU EXTENSION 5 FILED
Tuesday, June 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU EXTENSION 4 GRANTED
Tuesday, December 6, 2022SOU EXTENSION 4 FILED
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2022SOU EXTENSION 3 GRANTED
Tuesday, May 31, 2022SOU EXTENSION 3 FILED
Tuesday, May 31, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 2 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 2 FILED
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021SOU EXTENSION 1 GRANTED
Friday, June 4, 2021SOU EXTENSION 1 FILED
Friday, June 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 21, 2020NON-FINAL ACTION E-MAILED
Friday, February 21, 2020NON-FINAL ACTION WRITTEN
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2019NEW APPLICATION ENTERED

Related Keywords

kalmpen withdrawal opioid pharmaceuticals injectable agitation treatment other related central disorders